Access Global Healthcare Deal Flow
Sabil Health delivers pre-qualified, scored opportunities from the world's most promising healthcare startups and life sciences funds — starting with Europe's deepest pipeline. Matched to your mandate. No noise. No cold outreach. Just high-quality deal flow.
Here's What You Receive
Every opportunity arrives as a confidential memo — anonymized, scored, and verified by our team.
CONFIDENTIAL INVESTMENT MEMO
SH-INN-2026-00047
Vertical
Biotech
Stage
Phase II
Country
France
Raising
€15M
Summary
Clinical-stage biotech developing a first-in-class oral therapy for a large inflammatory disease indication. Phase II data showed statistically significant efficacy (p<0.001). Strong IP portfolio with 12 granted patents. Experienced management team with 2 prior exits. Seeking Series B to fund Phase III.
Compatibility Breakdown
Identity revealed only after mutual interest + NCA
Why Sabil Health
Pre-Qualified Deal Flow
Every startup and fund on our platform has been screened by our dual-expert team. You receive only opportunities that meet our quality threshold and match your investment criteria.
Intelligence Hub
Access market trends, sector deep dives, case studies, and investment frameworks. Stay ahead of the healthcare investment landscape with curated intelligence from our research team.
Vertical Explorer
Navigate healthcare by segment — from biotech to surgical robotics. Real market data, growth rates, key players, and investment theses for each vertical.
Confidential Deal Rooms
When mutual interest is confirmed, a secure Deal Room opens — NDA management, document sharing, real-time messaging, and milestone tracking, all in one place.
Founding Allocator Program
The first 20 allocators accepted to the platform become Founding Allocators.
- No platform fees for your first year
- First access to the highest-scored opportunities
- Dedicated relationship manager
- Input on platform features and matching criteria
- Founding Allocator designation visible to startups and funds
- AI-powered due diligence summaries (coming soon)
Spots are limited and allocated on a rolling basis.
We are currently in private beta. Leave your email below and we'll notify you when applications open.